Trials / Completed
CompletedNCT03735043
Cardiac Output Monitoring by ccNexfin© in Pregnant Women
Continuous Non-invasive Cardiac Output, an Evaluation of ccNexfin© in a Pregnant Population
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Variations of cardiac output are frequent in pregnant women during obstetrical procedures, and may participate to poor foetal outcomes through decrease of uteroplacental bloodflow. Thus, monitoring maternal cardiac output appears of major interest, as it would open the way to early initiation of hemodynamic supportive management. The ccNexfin© is a non-invasive hemodynamic monitoring device, whose relevance for continuous monitoring of cardiac output has been reported in a non-pregnant population. The hypothesis is that ccNexfin© gives acceptable measurement of maternal cardiac output in pregnant women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | cardiac output by ccNexfin © | Measurement of cardiac output by ccNexfin © comparatively to transthoracic echocardiography Subjects participating to the study will be simultaneously measured for cardiac output by ccNexfin © and transthoracic echocardiography. Echocardiographic measurements of cardiac output will be blinded to values measured by ccNexfin ©. For each participant, a first measurement of cardiac output will be performed in the supine position and then after 1 minute of strict left lateral position. |
Timeline
- Start date
- 2019-07-02
- Primary completion
- 2020-06-01
- Completion
- 2020-06-01
- First posted
- 2018-11-08
- Last updated
- 2021-03-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03735043. Inclusion in this directory is not an endorsement.